{"id":"W2158681922","doi":"10.1016/s1470-2045(09)70025-7","title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7801,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Ontario Institute for Cancer Research; Queen's University; Hôpital Notre-Dame; Western University; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Temozolomide; Radiation therapy; Concomitant; Internal medicine; Hazard ratio; Clinical endpoint; Oncology; Adjuvant; Cancer; Clinical trial; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}